Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>Products>This Product

Biochrom EZ Read 400 ELISA Microplate Reader

Product Description

BIO JOB 072_product image copy.gif

The EZ Read 400 is a cost-effective and easy to use microplate reader; it is a filter-based instrument that offers flexibility and full performance with no redundant features, the PC-controlled EZ Read 400 can be tailored to suit application requirements.

The ability to perform single or dual wavelength measurements to incorporate reference wavelength readings, and the option to do so at timed-intervals, means the EZ Read 400 is ideal for ELISA, protein, cell biology and kinetic assays. Designed to take up the minimum of bench space, and incorporating ADAP Basic PC software and USB connections for easy instrument to computer connection and data transfer, the new EZ Read 400 can be configured with a choice of:

• Filter options within a wavelength range of 400-750 nm
• Data analysis software packages
• QC plate for instrument validation

To meet the varying needs of modern laboratories, the EZ Read 400 is available in three basic models, each of which can be upgraded with either the ADAP Plus or ADAP Expert software options for even more powerful instrument control and application specific analysis:

1. ELISA Microplate Reader – filters for PNPP, ABTS, OPD, Slow TMB, Turbo TMB, and Ultra TMB assay substrates are included, with a reference filter.
2. Research Microplate Reader – ELISA assay filters are included along with filters for Bradford, BCA, and Lowry protein assays, and MTT, XTT, and turbidity cell counting cell biology-based assays. A reference filter is also included.
3. Flexi Microplate Reader – delivered as standard with 405, 450, 492, and 620 nm filters and up to four additional filters of choice, available in one nm increments between 400 and 750 nm.

80-4001-40    Biochrom EZ Read 400 ELISA Microplate Reader
80-4001-41    Biochrom EZ Read 400 Research Microplate Reader
80-4001-42    Biochrom EZ Read Flexi Microplate Reader
SS01751        QC Plate for instrument validation
B032082        ADAP Plus Data Analysis Software
B032083        ADAP Expert Data Analysis Software

Product Biochrom EZ Read 400 ELISA Microplate Reader
Company Biochrom Ltd - Product
Price Request a quote
More Information View company product page
Catalog Number 80-4001-40
Quantity Unspecified
Company Logo

Biochrom Ltd - Product
22 Cambridge Science Park Milton Road Cambridge CB4 0FJ UK

Tel: +44 (0) 1223 423723


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Targeting Cannabinoid CB2 Receptors in the CNS
With endogenous cannabinoids considered as a potential target to combat CNS diseases, this article examines the role of CB2R could play in fighting some disorders.
Bacterial Genes Boost Current in Human Cells
Borrowing and tweaking bacterial genes to enhance electrical activity might treat heart, nervous system injury.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
Cocoa Compound Linked to Some Cardiovascular Biomarker Improvements
The study highlights the urgent need for large, long-term RCTs that improve understanding of how the short-term benefits of cocoa flavanol intake on cardiometabolic biomarkers may be translated into clinical outcomes.
Untangling a Cause of Memory Loss in Neurodegenerative Diseases
The mouse study identifies a possible therapeutic target for a family of disorders.
New Pathway for COPD Biomarker Development
A study from Philip Morris International has highlighted multi-lipid profiling as a potential new pathway for COPD biomarker development.
Stiffening a Blow to Cancer Cells
Researchers develop a way to predict how a tumor tissue's physical properties affect its response to chemotherapy drugs.
Anti-Cancer Drug Uses Tumour mRNA to Identify Responders
Phase I study of novel anti-cancer drug uses tumour mRNA expression to identify patients who will respond to the drug.
New Strategy for Choosing Cancer Drugs
Device can predict tumor responses by measuring cell growth after drug exposure.

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,100+ scientific videos